In a distinctly upward trend, total venture capital financings in medical technology for the month of January 2010 hit $514 million. This eclipses the high month total of $440 in July 2009.
Key financings for the month include:
- $64.00 million, Intuity Medical, Inc., has raised $64 million in Series D financing (integrated blood glucose monitor)
- $32.50 million, CircuLite, Inc., has closed a Series C funding of $32.5 million (micro-pump for circulatory support in congestive heart failure)
- $31.20 million, Cellular Dynamics International, Inc., has raised $31.3 million in funding according to a regulatory filing (pluripotent stem cells, such as cardiomyocytes, used for drug discovery)
- $31.00 million, Tandem Diabetes has raised $31 million in funding, bringing its current round to $52.3 million (insulin pumps)
- $30.00 million, CeQur SA has raised $30 million in a Series A funding (subcutaneous insulin patch for Type 2 diabetes)
- $30.00 million, NeoMend, Inc., has received $30 million in funding (products used in sealing of surgical wounds)
- $25.45 million, Proteus Biomedical, Inc., has raised $25.45 million in a new funding round according to a regulatory filing (management of congestive heart failure)
- $22.50 million, Microfabrica, Inc., has raised $22.5 million in Series B funding (minimally invasive medical devices)
- $22.00 million, ValenTx Inc. has raised $22 million in a Series B funding ( less-invasive, implantable medical device to address morbid obesity)
For the complete list of financings for January 2010, see link.